NONOF News and Press, Novo-Nordisk A/S From 06/18/24

2024-06-18 11:26:22 ET Summary Novo Nordisk is a growth stock that continues to pleasantly surprise me and investors with the pace of its development of product candidates for the treatment of endocrine diseases. The company's share price reflects optimism about its diabetes franc...

2024-06-18 11:16:16 ET More on Novo Nordisk Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk: Considerable Growth Beyond Ozempic Ozempic drives more demand for small...

2024-06-17 11:30:03 ET Summary Amgen continues to delight investors with the growth in sales of its key blockbusters and the expansion of its portfolio of medications. In mid-June, Amgen pleased investors by announcing that the FDA had approved Blincyto to treat certain patients w...

2024-06-15 07:28:25 ET More on Novo Nordisk Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk: Considerable Growth Beyond Ozempic Employee benefits survey finds marke...

2024-06-14 10:24:55 ET Summary Structure Therapeutics Inc. shares surged over 50% on positive GSBR-1290 data, competing with other oral GLP-1R clinical rivals. However, GSBR-1290's efficacy at week 12 fell below Novo Nordisk's amycretin, but still competitive in the obesity treatm...

2024-06-14 08:01:46 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? ...

2024-06-13 09:49:40 ET More on JPMorgan Chase JPMorgan Chase & Co. (JPM) Morgan Stanley US Financials, Payments & CRE Conference JPMorgan Chase: Just By Opening 500 New Branches, It Could Potentially Generate Another $9.11B In Revenues JPMorgan Chase hires fo...

2024-06-13 08:58:36 ET More on Vivani Medical Seeking Alpha’s Quant Rating on Vivani Medical Historical earnings data for Vivani Medical Financial information for Vivani Medical Read the full article on Seeking Alpha For further details see: ...

2024-06-12 10:16:29 ET Summary Madrigal Pharmaceuticals, Inc. stock has enjoyed peaks and troughs as it has pursued its path to the approval of NASH drug Rezdiffra. The company's stock was buoyant yesterday, enjoying a 15% gain after Wolfe Research initiated positive coverage. ...

2024-06-11 15:42:39 ET More on Corbus Pharmaceuticals Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025 Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology Corbus outlines phase 1 results from ADC trial for bladder, ce...